Two new radioisotope production facilities are coming to the University of Missouri Research Reactor. The new production suite and support facility will be used to increase the production of NCA ...
NorthStar’s high purity non-carrier added (n.c.a.) Ac-225 to be used in Curadh’s molecularly targeted radiation (MTR) programs for treatment of solid tumors NorthStar is positioned to be the first ...
By rethinking operational models, radiopharma leaders can mitigate risks, increase efficiency and ensure reliable access to ...
BELOIT, Wis.--(BUSINESS WIRE)--NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications ...
Lætitia H. Delmau, recipient of the prestigious 2024 Glenn T. Seaborg Actinide Separations Award and a distinguished radiochemist in the Radioisotope Science and Technology Division at Oak Ridge ...